Ambra Bio

San Diego, United States Founded: 2014 • Age: 12 yrs
Developer of dietary supplements and medical foods
Request Access

About Ambra Bio

Ambra Bio is a company based in San Diego (United States) founded in 2014.. Ambra Bio has raised $1.82 million across 4 funding rounds. Ambra Bio operates in a competitive market with competitors including Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ambra Bioscience Llc
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.82 M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.05 M (USD), Debt – Conventional

    Dec 11, 2017

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Ambra Bio
Headcount 10-50
Employee Profiles 1
Board Members and Advisors 5
Employee Profiles
People
Martin R. Brown
CEO

Unlock access to complete

Board Members and Advisors
people
Alain D. Baron
Advisor

Unlock access to complete

Teams

Funding Insights of Ambra Bio

Ambra Bio has successfully raised a total of $1.82M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.05 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Debt – Conventional — $1.1M
  • First Round

    (16 Jan 2015)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2017 Amount Debt – Conventional - Ambra Bio Valuation

investors

May, 2017 Amount Debt – Conventional - Ambra Bio Valuation

investors

Sep, 2016 Amount Seed - Ambra Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Ambra Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ambra Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ambra Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ambra Bio

Ambra Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Natural extract products for immune-mediated diseases are provided.
domain founded_year HQ Location
Medical foods are developed using nutrigenomics and bioinformatics models.
domain founded_year HQ Location
Therapeutics and medical foods are developed for various diseases.
domain founded_year HQ Location
Medical foods for digestive disorders are developed and produced.
domain founded_year HQ Location
Customized early-life nutrition meals are delivered biweekly to homes.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ambra Bio

Frequently Asked Questions about Ambra Bio

When was Ambra Bio founded?

Ambra Bio was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Ambra Bio located?

Ambra Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Ambra Bio a funded company?

Ambra Bio is a funded company, having raised a total of $1.82M across 4 funding rounds to date. The company's 1st funding round was a Seed of $650K, raised on Jan 16, 2015.

What does Ambra Bio do?

Ambra Bio was founded in 2014 in San Diego, United States, within the biotechnology sector focused on health products. Dietary supplements and medical foods are developed to address metabolic and inflammatory conditions. The Gut Sensory Modulation platform is employed to stimulate L-cell hormone release in the lower gut, influencing hunger, glucose regulation, inflammation, and mood. The primary product, Lovidia, is provided as a supplement for hunger management.

Who are the top competitors of Ambra Bio?

Ambra Bio's top competitors include Uute Scientific, Filament BioSolutions and WellGen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available